Pharmaceutical Polymers / Medical Polymers Market - Distribution by Type of Polymer (Thermoplastic Polymers, Elastomers, Thermoset Polymers and Others), Area of Application (Medical Devices, Excipients, Packaging and Others) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035
The global pharmaceutical polymer / medical polymers market is expected to reach USD 20 billion in 2023 anticipated to grow at a CAGR of 7.3% during the forecast period 2023-2035.
Polymers, composed of diverse monomers, constitute an exceptionally adaptable class of materials. They are categorized as natural or synthetic based on their origins. Synthetic polymers encompass thermoplastics, elastomers, and fibers, while natural ones include substances like natural rubber, bio-based polymers, and wood. These materials possess economic feasibility, exceptional durability, chemical resistance, significant strength, and lightweight properties, making them highly valuable across a range of industries such as automotive, agriculture, construction, electronics, medicine, and textiles.
Within the medical sphere, polymers play a pivotal role. Medical-grade polymers serve multifaceted purposes in drug development and manufacturing. They aid in improving drug solubility, stability, and taste, as well as encapsulating drugs to mitigate unpleasant flavors. These polymers also facilitate the development of sustained-release drug delivery systems, ensuring controlled release over time or targeted delivery to specific tissues. Additionally, they form the basis of various medical devices like artificial joints, biosensors, dental implants, microfluidic devices, orthopedic implants, and stents.
In the realm of tissue engineering, pharmaceutical polymers wield substantial influence. They contribute to fabricating scaffolds that assist in repairing damaged tissues and wound care. Moreover, medical-grade polymers play a crucial role in 3D bioprinting, enabling the creation of hydrogels and bioinks used for generating soft tissues and supportive structures. The notable advancements in this field, coupled with a growing demand for innovative therapies and medical devices, anticipate significant growth in the global pharmaceutical and medical polymers market in the foreseeable future.
Report Coverage
Polymers, composed of diverse monomers, constitute an exceptionally adaptable class of materials. They are categorized as natural or synthetic based on their origins. Synthetic polymers encompass thermoplastics, elastomers, and fibers, while natural ones include substances like natural rubber, bio-based polymers, and wood. These materials possess economic feasibility, exceptional durability, chemical resistance, significant strength, and lightweight properties, making them highly valuable across a range of industries such as automotive, agriculture, construction, electronics, medicine, and textiles.
Within the medical sphere, polymers play a pivotal role. Medical-grade polymers serve multifaceted purposes in drug development and manufacturing. They aid in improving drug solubility, stability, and taste, as well as encapsulating drugs to mitigate unpleasant flavors. These polymers also facilitate the development of sustained-release drug delivery systems, ensuring controlled release over time or targeted delivery to specific tissues. Additionally, they form the basis of various medical devices like artificial joints, biosensors, dental implants, microfluidic devices, orthopedic implants, and stents.
In the realm of tissue engineering, pharmaceutical polymers wield substantial influence. They contribute to fabricating scaffolds that assist in repairing damaged tissues and wound care. Moreover, medical-grade polymers play a crucial role in 3D bioprinting, enabling the creation of hydrogels and bioinks used for generating soft tissues and supportive structures. The notable advancements in this field, coupled with a growing demand for innovative therapies and medical devices, anticipate significant growth in the global pharmaceutical and medical polymers market in the foreseeable future.
Report Coverage
- An executive summary of the insights captured during research. It offers a high-level view on the current state of the pharmaceutical polymers / medical polymers market and its likely evolution in the mid-long term.
- A brief overview of polymers, their historical background and properties, such as physical, chemical and mechanical. It also provides information on the different types of polymers (based on a variety of parameters) and their applications in the pharmaceutical / medical domain.
- A detailed assessment of the overall market landscape of companies manufacturing pharmaceutical polymers / medical polymers, based on several relevant parameters, such as year of establishment, company size, location of headquarters, source of polymer, composition of polymer, type of polymer, method of processing, method of sterilization, and area of application.
- A competitiveness analysis of pharmaceutical polymer / medical polymer manufacturers based in North America, Europe, Asia-Pacific and rest of world. The analysis compares various manufacturers based on supplier power (in terms of number of years of experience), service portfolio strength (in terms of source of polymer, number of types of polymers, number of application area and biodegradability of polymers) and number of compositions of polymer.
- Detailed profiles of key players engaged in the manufacturing of pharmaceutical polymers / medical polymers (shortlisted based on proprietary criteria) based in North America, Europe and Asia. Each profile features a brief overview of the company, along with information on its pharmaceutical polymers / medical polymers focused portfolio, recent developments and an informed future outlook.
- A detailed analysis of the partnerships inked between stakeholders engaged in this domain, since 2019, based on several relevant parameters, such as year of partnership, type of partnership, composition of polymer, type of polymer, area of application, type of partner, most active players (in terms of number of partnerships) and regional distribution of partnership activity.
- An insightful analysis of the leading pharmaceutical polymer / medical polymer manufacturers, considering the affiliated factors, key drivers, and challenges under the DELT framework, highlighting the relative effect of each factor of DELT parameter on the pharmaceutical polymer / medical polymer manufacturers.
- An overview of recent emerging trends in the domain of pharmaceutical polymers / medical polymers, highlighting information on the novel polymers (such as biodegradable polymers and smart polymers) and the polymer recycling initiatives adopted by manufacturers for maintaining a sustainable environment.
- Distribution of the future opportunity across, type of polymer (thermoplastic polymers, elastomers, thermoset polymers and others), area of application (medical devices, excipients, packaging and others) and geographical regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the world). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios of the industry’s evolution.
- Americhem
- Borealis
- Celanese
- Corel Pharma Chem
- Eastman
- Henkel
- KRAIBURG TPE
- Kuraray
- Lubrizol Life Science
- LyondellBasell
- Phon Tech
- SEQENS
- Sumitomo Chemical
- Solvay
- Zylog ElastoComp
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Polymers
3.2.1 Historical Development of Polymers
3.2.2 Properties of Polymers
3.2.2.1 Physical Properties
3.2.2.1 Chemical Properties
3.2.2.2 Mechanical Properties
3.2.3 Classification of Polymers
3.2.3.1 Classification based on Molecular Forces
3.2.3.2 Classification based on Origin of Source
3.2.3.3 Classification based on Structure of Molecular Chain
3.2.3.4 Classification based on Monomers
3.2.3.5 Classification based on Backbone Chain
3.2.3.6 Classification based on Degradation Capability
3.2.3.7 Classification based on Morphology
3.2.4 Applications of Polymers in Pharmaceutical / Medical Domain
3.2.4.1 Pharmaceutical Formulation
3.2.4.2 Drug Delivery System
3.2.4.3 Gene Therapy
3.2.4.4 Stability Enhancer
3.2.4.5 Vaccine Adjuvant
3.2.4.6 Tissue Engineering
3.2.4.7 Dentistry
3.2.4.8 Packaging
3.2.4.9 Medical Device Coating
3.2.4.10 Others
3.3. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Polymer / Medical Polymer Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Source of Polymer
4.2.6. Analysis by Composition of Polymer
4.2.7. Analysis by Type of Polymer
4.2.8. Analysis by Area of Application
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis
5.4.1. Company Competitiveness Analysis: Players based in North America
5.4.2. Company Competitiveness Analysis: Players based in Europe
5.4.3. Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the World
6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Americhem
6.2.1. Company Overview
6.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Celanese
6.3.1. Company Overview
6.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Eastman
6.4.1. Company Overview
6.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Lubrizol Life Science
6.5.1. Company Overview
6.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. LyondellBasell
6.6.1. Company Overview
6.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.6.3. Recent Developments and Future Outlook
7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE
7.1. Chapter Overview
7.2. Borealis
7.2.1. Company Overview
7.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Henkel
7.3.1. Company Overview
7.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. KRAIBURG TPE
7.4.1. Company Overview
7.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. SEQENS
7.5.1. Company Overview
7.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Solvay
7.6.1. Company Overview
7.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD
8.1. Chapter Overview
8.2. Corel Pharma Chem
8.2.1. Company Overview
8.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Kuraray
8.3.1. Company Overview
8.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Phon Tech
8.4.1. Company Overview
8.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Sumitomo Chemical
8.5.1. Company Overview
8.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Zylog ElastoComp
8.6.1. Company Overview
8.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.6.3. Recent Developments and Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Composition of Polymer
9.3.5. Analysis by Type of Polymer
9.3.6. Analysis by Type of Partnership and Type of Polymer
9.3.7. Analysis by Area of Application
9.3.8. Analysis by Type of Partner
9.3.9. Most Active Players: Analysis by Number of Partnerships
9.3.10. Analysis by Geography
9.3.10.1. Intracontinental and Intercontinental Deals
9.3.10.2. International and Local Deals
10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Key Parameters
10.3.1. Demographical Factors
10.3.2. Environmental Factors
10.3.3. Legal Factors
10.3.4. Technological Factors
10.4. DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers
10.4.1. Arkema
10.4.2. Boron Molecular
10.4.3. Celanese
10.4.4. Chempilots
10.4.5. DSM
10.4.6. Evonik
10.4.7. Foryou Medical
10.4.8. JenKem Technology
10.4.9. Kraton
10.4.10. Kuraray
10.4.11. PolyVation
10.4.12. Polyzen
10.4.13. Zylog ElastoComp
10.5. Concluding Remarks
11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS
11.1 Chapter Overview
11.2 Recent Trends Related to Pharmaceutical / Medical Polymers
11.2.1 Development of Novel Pharmaceutical / Medical Polymers
11.2.1.1. Biodegradable Polymers
11.2.1.2. Smart Polymers
11.2.2. Recycling of Pharmaceutical / Medical Polymers
11.3. Concluding Remarks
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Pharmaceutical Polymers / Medical Polymers Market, 2023-2035
12.3.1. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Type of Polymer, 2023 and 2035
12.3.1.1. Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035
12.3.1.2. Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035
12.3.1.3. Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035
12.3.1.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.2. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Area of Application, 2023 and 2035
12.3.2.1. Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035
12.3.2.2. Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035
12.3.2.3. Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035
12.3.2.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.3. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Geography, 2023 and 2035
12.3.3.1. Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035
12.3.3.2. Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Asia-Pacific, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Cassion Biotech
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Thomas A. Harlan, Chief Executive Officer and Paul L. Deangelis, Chief Scientist
14.3. Celares
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Michael Joachim Sefkow, Business Development Manager
14.4. Daikyo Seiko
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Risako Tanaka, Head of Marketing and Business Strategy
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Polymers
3.2.1 Historical Development of Polymers
3.2.2 Properties of Polymers
3.2.2.1 Physical Properties
3.2.2.1 Chemical Properties
3.2.2.2 Mechanical Properties
3.2.3 Classification of Polymers
3.2.3.1 Classification based on Molecular Forces
3.2.3.2 Classification based on Origin of Source
3.2.3.3 Classification based on Structure of Molecular Chain
3.2.3.4 Classification based on Monomers
3.2.3.5 Classification based on Backbone Chain
3.2.3.6 Classification based on Degradation Capability
3.2.3.7 Classification based on Morphology
3.2.4 Applications of Polymers in Pharmaceutical / Medical Domain
3.2.4.1 Pharmaceutical Formulation
3.2.4.2 Drug Delivery System
3.2.4.3 Gene Therapy
3.2.4.4 Stability Enhancer
3.2.4.5 Vaccine Adjuvant
3.2.4.6 Tissue Engineering
3.2.4.7 Dentistry
3.2.4.8 Packaging
3.2.4.9 Medical Device Coating
3.2.4.10 Others
3.3. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Polymer / Medical Polymer Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Source of Polymer
4.2.6. Analysis by Composition of Polymer
4.2.7. Analysis by Type of Polymer
4.2.8. Analysis by Area of Application
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis
5.4.1. Company Competitiveness Analysis: Players based in North America
5.4.2. Company Competitiveness Analysis: Players based in Europe
5.4.3. Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the World
6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Americhem
6.2.1. Company Overview
6.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Celanese
6.3.1. Company Overview
6.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Eastman
6.4.1. Company Overview
6.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Lubrizol Life Science
6.5.1. Company Overview
6.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. LyondellBasell
6.6.1. Company Overview
6.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.6.3. Recent Developments and Future Outlook
7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE
7.1. Chapter Overview
7.2. Borealis
7.2.1. Company Overview
7.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Henkel
7.3.1. Company Overview
7.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. KRAIBURG TPE
7.4.1. Company Overview
7.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. SEQENS
7.5.1. Company Overview
7.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Solvay
7.6.1. Company Overview
7.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD
8.1. Chapter Overview
8.2. Corel Pharma Chem
8.2.1. Company Overview
8.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Kuraray
8.3.1. Company Overview
8.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Phon Tech
8.4.1. Company Overview
8.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Sumitomo Chemical
8.5.1. Company Overview
8.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Zylog ElastoComp
8.6.1. Company Overview
8.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.6.3. Recent Developments and Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Composition of Polymer
9.3.5. Analysis by Type of Polymer
9.3.6. Analysis by Type of Partnership and Type of Polymer
9.3.7. Analysis by Area of Application
9.3.8. Analysis by Type of Partner
9.3.9. Most Active Players: Analysis by Number of Partnerships
9.3.10. Analysis by Geography
9.3.10.1. Intracontinental and Intercontinental Deals
9.3.10.2. International and Local Deals
10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Key Parameters
10.3.1. Demographical Factors
10.3.2. Environmental Factors
10.3.3. Legal Factors
10.3.4. Technological Factors
10.4. DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers
10.4.1. Arkema
10.4.2. Boron Molecular
10.4.3. Celanese
10.4.4. Chempilots
10.4.5. DSM
10.4.6. Evonik
10.4.7. Foryou Medical
10.4.8. JenKem Technology
10.4.9. Kraton
10.4.10. Kuraray
10.4.11. PolyVation
10.4.12. Polyzen
10.4.13. Zylog ElastoComp
10.5. Concluding Remarks
11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS
11.1 Chapter Overview
11.2 Recent Trends Related to Pharmaceutical / Medical Polymers
11.2.1 Development of Novel Pharmaceutical / Medical Polymers
11.2.1.1. Biodegradable Polymers
11.2.1.2. Smart Polymers
11.2.2. Recycling of Pharmaceutical / Medical Polymers
11.3. Concluding Remarks
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Pharmaceutical Polymers / Medical Polymers Market, 2023-2035
12.3.1. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Type of Polymer, 2023 and 2035
12.3.1.1. Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035
12.3.1.2. Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035
12.3.1.3. Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035
12.3.1.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.2. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Area of Application, 2023 and 2035
12.3.2.1. Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035
12.3.2.2. Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035
12.3.2.3. Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035
12.3.2.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.3. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Geography, 2023 and 2035
12.3.3.1. Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035
12.3.3.2. Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Asia-Pacific, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Cassion Biotech
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Thomas A. Harlan, Chief Executive Officer and Paul L. Deangelis, Chief Scientist
14.3. Celares
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Michael Joachim Sefkow, Business Development Manager
14.4. Daikyo Seiko
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Risako Tanaka, Head of Marketing and Business Strategy
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
